アステラス製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/06/14 | 2,288.5 | 2,297 | 2,273 | 2,286 | -4.5 | -0.2% | 4,545,200 |
2023/06/13 | 2,296 | 2,299.5 | 2,280 | 2,290.5 | +13.5 | +0.6% | 4,027,700 |
2023/06/12 | 2,275 | 2,294 | 2,260 | 2,277 | +17.5 | +0.8% | 3,802,900 |
2023/06/09 | 2,258 | 2,275 | 2,239.5 | 2,259.5 | +25.5 | +1.1% | 7,586,000 |
2023/06/08 | 2,260 | 2,269 | 2,223 | 2,234 | -26 | -1.2% | 4,659,400 |
2023/06/07 | 2,296.5 | 2,312.5 | 2,256 | 2,260 | -45 | -2% | 5,306,400 |
2023/06/06 | 2,265 | 2,307.5 | 2,257 | 2,305 | +17.5 | +0.8% | 4,760,000 |
2023/06/05 | 2,273 | 2,288 | 2,251 | 2,287.5 | +58.5 | +2.6% | 4,996,000 |
2023/06/02 | 2,242.5 | 2,253.5 | 2,205 | 2,229 | -7 | -0.3% | 5,511,800 |
2023/06/01 | 2,220 | 2,237 | 2,210 | 2,236 | +28.5 | +1.3% | 5,162,900 |
2023/05/31 | 2,236 | 2,239.5 | 2,204.5 | 2,207.5 | -56.5 | -2.5% | 12,763,000 |
2023/05/30 | 2,292 | 2,308.5 | 2,254 | 2,264 | -32 | -1.4% | 5,061,700 |
2023/05/29 | 2,321 | 2,340 | 2,287.5 | 2,296 | -23.5 | -1% | 8,062,800 |
2023/05/26 | 2,333.5 | 2,345 | 2,319.5 | 2,319.5 | -21.5 | -0.9% | 5,777,700 |
2023/05/25 | 2,318 | 2,360.5 | 2,308.5 | 2,341 | +17 | +0.7% | 6,222,900 |
2023/05/24 | 2,324.5 | 2,338 | 2,315.5 | 2,324 | -4.5 | -0.2% | 3,885,900 |
2023/05/23 | 2,336.5 | 2,343 | 2,305 | 2,328.5 | +19.5 | +0.8% | 6,152,400 |
2023/05/22 | 2,280 | 2,309 | 2,274 | 2,309 | +41 | +1.8% | 4,661,900 |
2023/05/19 | 2,250 | 2,271.5 | 2,244 | 2,268 | +24.5 | +1.1% | 4,586,300 |
2023/05/18 | 2,232.5 | 2,245.5 | 2,215 | 2,243.5 | +4.5 | +0.2% | 5,522,700 |
2023/05/17 | 2,219.5 | 2,246 | 2,216 | 2,239 | +20 | +0.9% | 5,070,700 |
2023/05/16 | 2,192 | 2,219 | 2,190 | 2,219 | +43 | +2% | 7,097,900 |
2023/05/15 | 2,148 | 2,176 | 2,128.5 | 2,176 | +47 | +2.2% | 6,107,400 |
2023/05/12 | 2,152 | 2,152 | 2,110.5 | 2,129 | +27 | +1.3% | 6,577,700 |
2023/05/11 | 2,095 | 2,105 | 2,088 | 2,102 | +6.5 | +0.3% | 3,977,800 |
2023/05/10 | 2,095 | 2,102 | 2,086 | 2,095.5 | -13.5 | -0.6% | 5,466,600 |
2023/05/09 | 2,073.5 | 2,113.5 | 2,072 | 2,109 | +40 | +1.9% | 4,698,100 |
2023/05/08 | 2,087 | 2,088 | 2,057.5 | 2,069 | -11 | -0.5% | 6,241,000 |
2023/05/02 | 2,100 | 2,118 | 2,074.5 | 2,080 | -13 | -0.6% | 6,678,900 |
2023/05/01 | 2,030 | 2,098.5 | 2,030 | 2,093 | +45 | +2.2% | 6,810,000 |
2023/04/28 | 2,040 | 2,052.5 | 2,025 | 2,048 | +67 | +3.4% | 8,316,200 |
2023/04/27 | 1,980 | 1,987 | 1,972 | 1,981 | -8.5 | -0.4% | 5,682,600 |
2023/04/26 | 2,010 | 2,017 | 1,978.5 | 1,989.5 | -27 | -1.3% | 3,980,200 |
2023/04/25 | 2,002.5 | 2,024 | 1,997 | 2,016.5 | +4.5 | +0.2% | 3,768,700 |
2023/04/24 | 2,011 | 2,014.5 | 2,004.5 | 2,012 | +15.5 | +0.8% | 2,531,000 |
2023/04/21 | 1,989.5 | 2,002 | 1,983 | 1,996.5 | -3.5 | -0.2% | 3,128,200 |
2023/04/20 | 2,008.5 | 2,008.5 | 1,991 | 2,000 | -10.5 | -0.5% | 3,577,400 |
2023/04/19 | 2,007 | 2,017.5 | 2,001 | 2,010.5 | -4 | -0.2% | 3,814,800 |
2023/04/18 | 1,999.5 | 2,019 | 1,994 | 2,014.5 | +15 | +0.8% | 4,124,900 |
2023/04/17 | 1,980 | 2,003.5 | 1,975 | 1,999.5 | +51.5 | +2.6% | 6,595,400 |
2023/04/14 | 1,946 | 1,950 | 1,929 | 1,948 | +7 | +0.4% | 5,817,000 |
2023/04/13 | 1,931 | 1,946 | 1,926 | 1,941 | +16 | +0.8% | 4,523,500 |
2023/04/12 | 1,910 | 1,930 | 1,907.5 | 1,925 | ±0 | ±0% | 5,032,400 |
2023/04/11 | 1,924.5 | 1,939.5 | 1,918 | 1,925 | +6.5 | +0.3% | 3,841,800 |
2023/04/10 | 1,911 | 1,924.5 | 1,903 | 1,918.5 | +19 | +1% | 3,493,900 |
2023/04/07 | 1,915 | 1,917 | 1,895 | 1,899.5 | -26 | -1.4% | 3,178,100 |
2023/04/06 | 1,903 | 1,928.5 | 1,895 | 1,925.5 | +31.5 | +1.7% | 5,437,400 |
2023/04/05 | 1,922 | 1,924 | 1,887 | 1,894 | -28 | -1.5% | 4,506,300 |
2023/04/04 | 1,894 | 1,923.5 | 1,886 | 1,922 | +43.5 | +2.3% | 6,245,000 |
2023/04/03 | 1,885 | 1,888 | 1,877 | 1,878.5 | -4.5 | -0.2% | 4,159,000 |
401~
450
件表示中 / 3631件
類似銘柄と比較する
現在ご覧いただいている「アステラス薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
アステラス薬 | 151,400円 | +18.5% | -96.0% | 4.89% | 193.61倍 | 1.77倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
武 田 | 420,900円 | +7.7% | +206.9% | 4.66% | 56.54倍 | 0.96倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
大塚HD | 813,600円 | +14.4% | +120.8% | 1.47% | 18.21倍 | 1.67倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
塩野義 | 229,000円 | +5.7% | +3.9% | 2.50% | 11.39倍 | 1.51倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 462,100円 | +1.7% | -2.9% | 3.46% | 30.32倍 | 1.59倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
市場注目の銘柄
チャート関連のコラム